Cancer-associated fibroblast-derived SPP1 is a potential target for overcoming sorafenib and lenvatinib resistance in hepatocellular carcinoma. (October 2022) - Ahn, H.R.; Eun, J.W.; Yoon, J.H.; Son, J.A.; Weon, J.H.; Baek, G.O.; Yoon, M.G.; Han, J.E.; Kwon, M.; Kim, S.S.; Cheong, J.Y.; Cho, H.J.